Mark J. Pykett
2013
In 2013, Mark J. Pykett earned a total compensation of $1.1M as Chief Executive Officer at Navidea Biopharmaceuticals, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,500 |
|---|---|
| Option Awards | $557,448 |
| Salary | $433,500 |
| Other | $6,749 |
| Total | $1,125,197 |
Pykett received $557.4K in option awards, accounting for 50% of the total pay in 2013.
Pykett also received $127.5K in non-equity incentive plan, $433.5K in salary and $6.7K in other compensation.
Rankings
In 2013, Mark J. Pykett's compensation ranked 6,093rd out of 12,286 executives tracked by ExecPay. In other words, Pykett earned more than 50.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,093 out of 12,286 | 50th |
Division Manufacturing | 2,123 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 628 out of 1,466 | 57th |
Industry group Drugs | 452 out of 1,160 | 61st |
Industry In Vitro and In Vivo Diagnostic Substances | 21 out of 56 | 63rd |
Source: SEC filing on June 5, 2015.
Pykett's colleagues
We found four more compensation records of executives who worked with Mark J. Pykett at Navidea Biopharmaceuticals in 2013.
2013
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2013
Cornelia Reininger
Navidea Biopharmaceuticals
Chief Medical Officer
2013
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2013
Brent Larson
Navidea Biopharmaceuticals